Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.


 (ī′kôr′, ī′kər)
1. Greek Mythology The rarefied fluid said to run in the veins of the gods.
2. A watery, acrid discharge from a wound or ulcer.

[Middle English icor, from Late Latin īchōr, from Greek īkhōr.]

i′chor·ous (ī′kər-əs) adj.


1. (Classical Myth & Legend) Greek myth the fluid said to flow in the veins of the gods
2. (Pathology) pathol a foul-smelling watery discharge from a wound or ulcer
[C17: from Greek ikhōr, of obscure origin]
ˈichorous adj


(ˈaɪ kɔr, ˈaɪ kər)

1. the ethereal fluid flowing in the veins of the ancient Greek gods.
2. the watery ooze of a wound.
[1630–40; < Late Latin īchōr < Greek īchṓr]
i•chor•ous (ˈaɪ kər əs) adj.


a thin watery substance discharged from wounds or ulcers. See also god and gods. — ichorous, adj.
See also: Body, Human
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.ichor - (Greek mythology) the rarified fluid said to flow in the veins of the Gods
Greek mythology - the mythology of the ancient Greeks
fluid - a substance that is fluid at room temperature and pressure
2.ichor - a fluid product of inflammation
bodily fluid, body fluid, liquid body substance, humour, humor - the liquid parts of the body
gleet - a thin morbid discharge as from a wound or especially chronic gonorrhea
References in classic literature ?
The point tore through the ambrosial robe which the Graces had woven for her, and pierced the skin between her wrist and the palm of her hand, so that the immortal blood, or ichor, that flows in the veins of the blessed gods, came pouring from the wound; for the gods do not eat bread nor drink wine, hence they have no blood such as ours, and are immortal.
So saying, she wiped the ichor from the wrist of her daughter with both hands, whereon the pain left her, and her hand was healed.
Once having tasted this immortal ichor, he cannot have enough of it, and as an admirable creative power exists in these intellections, it is of the last importance that these things get spoken.
Since its inception in 1999, Ichor Systems has established strong relationships with the world's leading capital equipment manufacturers, collaborating on system design and serving as an outsourced manufacturer for complex subsystems.
May 7, 2014 /PRNewswire/ --Flextronics (NASDAQ: FLEX), a leading end-to-end supply chain solutions company, announced that its Medical Group will provide design and manufacturing services to Ichor Medical Systems for the development of its next generation TriGrid(TM) DNA Delivery System, an electroporation device used to deliver DNA vaccines and treatments addressing a broad spectrum of disease indications.
In addition, Scancell's partner Ichor Medical Systems
The funds will support proof-of-concept studies in non-human primates with proprietary, plasmid DNA (pDNA, delivered using the electroporation (EP) based TriGrid[TM]delivery system (TriGrid) developed by Ichor Medical Systems) and recombinant vesicular stomatitis virus (rVSV) vector technologies towards the development of a preventive malaria vaccine.
As part consideration for its grant of this licence, Ichor was
addition, Scancell and its partner Ichor Medical Systems
Study Designed to Establish the Optimal Dose of GENEVAX[TM] IL-12 Adjuvant in Formulation with the Profectus Multi-Antigen Therapeutic HIV DNA Vaccine when Delivered with the Ichor Medical Systems' TriGrid[TM] Electroporation Delivery Device
GeneCure Biotechnologies Genetic Immunity Genocea Biosciences GenPhar GenVec GeoVax Labs Geron GlaxoSmithKline (GSK) Glide Pharma Gliknik Global Health Innovative Technology Fund (GHIT Fund) GlobeImmune Gradalis Greer Laboratories Hawaii Biotech Health Protection Agency (HPA) Heat Biologics Helmholtz Centre for Infection Research iBio Ichor Medical Systems
Licensing agreement signed with Merck KGaA for two key patents required for further development and commercialisation of protein ImmunoBody vaccines * Agreement signed with Ichor Medical Systems to use Ichor's TriGrid(TM) electroporation device for the delivery of SCIB1 * Signed a research agreement with ImmunoVaccine Technologies Inc.